View in EDS HTML Full Text PDF Full Text

Combined plasma levels of A-type-natriuretic peptide and adrenomedullin are associated with appropriate anti-arrhythmia therapy in patients with an implantable cardioverter defibrillator but no prior device therapy.

Saved in:
Bibliographic Details
Title: Combined plasma levels of A-type-natriuretic peptide and adrenomedullin are associated with appropriate anti-arrhythmia therapy in patients with an implantable cardioverter defibrillator but no prior device therapy.
Authors: Beygui F; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France.; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France., Roule V; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France.; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France., Gandjbakhch E; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Ollitrault P; Cardiology Department, Caen University Hospital, Caen, France., Silvain J; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Milliez P; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France., Vignolles N; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Zeitouni M; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Guedeney P; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Champ-Rigot L; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France., Blanchart K; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France., Montalescot G; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France.
Source: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2025 Jul; Vol. 30 (5), pp. 371-379. Date of Electronic Publication: 2025 Sep 08.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Tayor & Francis Country of Publication: England NLM ID: 9606000 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1366-5804 (Electronic) Linking ISSN: 1354750X NLM ISO Abbreviation: Biomarkers Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40878542
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combined plasma levels of A-type-natriuretic peptide and adrenomedullin are associated with appropriate anti-arrhythmia therapy in patients with an implantable cardioverter defibrillator but no prior device therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Beygui+F%22">Beygui F</searchLink>; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France.; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Roule+V%22">Roule V</searchLink>; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France.; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.<br /><searchLink fieldCode="AU" term="%22Gandjbakhch+E%22">Gandjbakhch E</searchLink>; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ollitrault+P%22">Ollitrault P</searchLink>; Cardiology Department, Caen University Hospital, Caen, France.<br /><searchLink fieldCode="AU" term="%22Silvain+J%22">Silvain J</searchLink>; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Milliez+P%22">Milliez P</searchLink>; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France.<br /><searchLink fieldCode="AU" term="%22Vignolles+N%22">Vignolles N</searchLink>; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Zeitouni+M%22">Zeitouni M</searchLink>; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Guedeney+P%22">Guedeney P</searchLink>; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Champ-Rigot+L%22">Champ-Rigot L</searchLink>; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France.<br /><searchLink fieldCode="AU" term="%22Blanchart+K%22">Blanchart K</searchLink>; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France.<br /><searchLink fieldCode="AU" term="%22Montalescot+G%22">Montalescot G</searchLink>; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229606000%22">Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals</searchLink> [Biomarkers] 2025 Jul; Vol. 30 (5), pp. 371-379. <i>Date of Electronic Publication: </i>2025 Sep 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Tayor+%26+Francis%22">Tayor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9606000 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1366-5804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221354750X%22">1354750X </searchLink><i>NLM ISO Abbreviation: </i>Biomarkers <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40878542
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/1354750X.2025.2553630
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 371
    Titles:
      – TitleFull: Combined plasma levels of A-type-natriuretic peptide and adrenomedullin are associated with appropriate anti-arrhythmia therapy in patients with an implantable cardioverter defibrillator but no prior device therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Beygui F
      – PersonEntity:
          Name:
            NameFull: Roule V
      – PersonEntity:
          Name:
            NameFull: Gandjbakhch E
      – PersonEntity:
          Name:
            NameFull: Ollitrault P
      – PersonEntity:
          Name:
            NameFull: Silvain J
      – PersonEntity:
          Name:
            NameFull: Milliez P
      – PersonEntity:
          Name:
            NameFull: Vignolles N
      – PersonEntity:
          Name:
            NameFull: Zeitouni M
      – PersonEntity:
          Name:
            NameFull: Guedeney P
      – PersonEntity:
          Name:
            NameFull: Champ-Rigot L
      – PersonEntity:
          Name:
            NameFull: Blanchart K
      – PersonEntity:
          Name:
            NameFull: Montalescot G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1366-5804
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
              Type: main
ResultId 1